These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14770094)

  • 1. Comorbid conditions in patients with rheumatic diseases: an update.
    Wasko MC
    Curr Opin Rheumatol; 2004 Mar; 16(2):109-13. PubMed ID: 14770094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular co-morbidity in rheumatic diseases.
    Turesson C; Jacobsson LT; Matteson EL
    Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):305-15. PubMed ID: 20080915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
    Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
    Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity in rheumatoid arthritis.
    Turesson C
    Swiss Med Wkly; 2016; 146():w14290. PubMed ID: 27045333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
    Kerkhof PLM; Khamaganova I
    Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheumatic diseases as risk factors for cardiovascular disease].
    Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-morbidity in rheumatoid arthritis.
    Mikuls TR
    Best Pract Res Clin Rheumatol; 2003 Oct; 17(5):729-52. PubMed ID: 12915155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
    Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
    Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases].
    Bertin P
    Presse Med; 2006 Sep; 35 Suppl 1():5-9. PubMed ID: 17870548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular co-morbidity in patients with rheumatic diseases.
    Frostegård J
    Arthritis Res Ther; 2011 Jun; 13(3):225. PubMed ID: 21722331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
    Gabriel SE; Michaud K
    Arthritis Res Ther; 2009; 11(3):229. PubMed ID: 19519924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
    Schiff MH; DiVittorio G; Tesser J; Fleischmann R; Schechtman J; Hartman S; Liu T; Solinger AM
    Arthritis Rheum; 2004 Jun; 50(6):1752-60. PubMed ID: 15188350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?].
    Bertin P
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S5-9. PubMed ID: 17078590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in rheumatoid arthritis.
    Michaud K; Wolfe F
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):885-906. PubMed ID: 17870034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0.
    Ventura-Ríos L; Bañuelos-Ramírez D; Hernández-Quiroz Mdel C; Robles-San Román M; Irazoque-Palazuelos F; Goycochea-Robles MV
    Reumatol Clin; 2012; 8(4):189-94. PubMed ID: 22673388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular involvement in rheumatic diseases].
    Driazhenko IV
    Kardiologiia; 2005; 45(11):98-104. PubMed ID: 16353072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing comorbidity risks in rheumatoid arthritis.
    Dechant SA; Matteson EL
    Curr Opin Rheumatol; 2004 May; 16(3):177-9. PubMed ID: 15103241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.